Evidence map›Paper›PMID 26052556›Full record

ArticleJournal of reward deficiency syndrome

NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity.

Stephen J Schoenthaler, Kenneth Blum, Eric R Braverman, John Giordano, Ben Thompson, Marlene Oscar-Berman, Rajendra D Badgaiyan, Margaret A Madigan, Kristina Dushaj, Mona Li and 3 more

Abstract read
In one paragraph

Article in Journal of reward deficiency syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.International journal of environmental research and public health · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Stephen J SchoenthalerDepartment of Sociology, California State University, Turlock, CA, USA.
Kenneth BlumDepartment of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA ; Department of Neurology, PATH Foundation NY, New York, NY, USA ; Department of Clinical Research, National Institute for Holistic Addiction Studies, North Miami Beach, FL, USA ; Department of Psychiatry, Human Integrated Services Unit, University of Vermont Center for Clinical & Translational Science, University of Vermont College of Medicine, Burlington, VT, USA ; Department of Nutrigenomics, Igene, Inc., Austin, TX, USA ; Department of Addiction Research & Therapy, Malibu Beach Recovery Center, Malibu, CA, USA ; Dominion Diagnostics, LLC, North Kingston, RI, USA.
Eric R BravermanDepartment of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA ; Department of Neurology, PATH Foundation NY, New York, NY, USA.
John GiordanoDepartment of Clinical Research, National Institute for Holistic Addiction Studies, North Miami Beach, FL, USA.
Ben ThompsonDepartments of Psychiatry, Anatomy, & Neurobiology, Boston VA and Boston University School of Medicine, Boston, MA, USA.
Marlene Oscar-BermanDepartments of Psychiatry, Anatomy, & Neurobiology, Boston VA and Boston University School of Medicine, Boston, MA, USA.
Rajendra D BadgaiyanDepartment of Psychiatry, University of Minnesota College of Medicine, Minneapolis, MN, USA.
Margaret A MadiganDepartment of Nutrigenomics, Igene, Inc., Austin, TX, USA.
Kristina DushajDepartment of Neurology, PATH Foundation NY, New York, NY, USA.
Mona LiDepartment of Neurology, PATH Foundation NY, New York, NY, USA.
Zsolt DemotrovicsEotvos Lorand University, Institute of Psychology, Department of Clinical Psychology and Addiction, Izabella utca 46, H-1064, Budapest, Hungary.
Roger L WaiteDepartment of Nutrigenomics, RDSolutions, Inc., Salt Lake City, UT, USA.
Mark S GoldDirector of Research, Drug Enforcement Administration (DEA) Educational Foundation, Washington, D.C, USA ; Departments of Psychiatry & Behavioral Sciences at the Keck, University of Southern California, School of Medicine, CA, USA.

Funding

AFFECTIVE AND CONATIVE CHANGES IN ALCOHOLISMR01AA007112 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BERMAN, MARLENE OSCAR · 1987 to 2019
$8.3M
Dopamine Neurotransmission in Tourette SyndromeR01NS073884 · NINDS · UNIVERSITY OF MINNESOTA · PI BADGAIYAN, RAJENDRA D · 2012 to 2016
$2.2M
Detection of Dopamine Release During a Cognitive TaskR21MH073624 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BADGAIYAN, RAJENDRA D · 2005 to 2006
$368k
Dopamine Neurotransmission in AddictionI01CX000479 · VA · VA WESTERN NEW YORK HEALTHCARE SYSTEM · PI BADGAIYAN, RAJENDRA D · 2013 to 2014
–
CSRD VA I01 CX000479NIAAA NIH HHS R01 AA007112NIMH NIH HHS R21 MH073624NINDS NIH HHS R01 NS073884
6 · The paper itself

Abstract

backgroundThe connection between religion/spirituality and deviance, like substance abuse, was first made by Durkheim who defined socially expected behaviors as norms. He explained that deviance is due in large part to their absence (called anomie), and concluded that spirituality lowers deviance by preserving norms and social bonds. Impairments in brain reward circuitry, as observed in Reward Deficiency Syndrome (RDS), may also result in deviance and as such we wondered if stronger belief in spirituality practice and religious belief could lower relapse from drugs of abuse.

methodsThe NIDA Drug Addiction Treatment Outcome Study data set was used to examine post hoc relapse rates among 2,947 clients who were interviewed at 12 months after intake broken down by five spirituality measures.

resultsOur main findings strongly indicate, that those with low spirituality have higher relapse rates and those with high spirituality have higher remission rates with crack use being the sole exception. We found significant differences in terms of cocaine, heroin, alcohol, and marijuana relapse as a function of strength of religious beliefs (x

conclusionsStronger spiritual/religious beliefs and practices are directly associated with remission from abused drugs except crack. Much like the value of having a sponsor, for clients who abuse drugs, regular spiritual practice, particularly weekly attendance at the religious services of their choice is associated with significantly higher remission. These results demonstrate the clinically significant role of spirituality and the social bonds it creates in drug treatment programs.

Indexed as

AnomieGenospiritualityNeurogenticsRelapseReligionReward Deficiency Syndrome (RDS)Social BondsSpirituality

Identifiers

PMID26052556
PMCPMC4455957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.